Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial

Dry eye disease (DED) is a multifactorial disorder characterized by loss of tear film homeostasis, which initiates a cycle of ocular surface inflammation and damage. As ocular discomfort symptoms associated with DED can decrease quality of life, affected patients prefer treatments that rapidly impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Schechter, Barry A, Urbieta, Maitee, Bacharach, Jason, Toyos, Melissa, Smyth-Medina, Robert, Mitchell, Brittany, Luchs, Jodi I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759017/
https://www.ncbi.nlm.nih.gov/pubmed/36536927
http://dx.doi.org/10.2147/OPTH.S392315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759017/
https://www.ncbi.nlm.nih.gov/pubmed/36536927
http://dx.doi.org/10.2147/OPTH.S392315

Ejemplares similares